Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06401551 · ClinicalTrials.gov registry record · NA
Clareon PanOptix Pro vs. Clareon PanOptix - Study B
A NA study of Presbyopia and Aphakia, sponsored by Alcon Research.
- Completed
- Registry status
- NA
- Development phase
- 71
- Enrollment target
- 8
- Study locations
NCT06401551: Completed NA study of Presbyopia and Aphakia, sponsored by Alcon Research.
NCT06401551 is a NA study of Presbyopia and Aphakia that has completed, run by Alcon Research. The registered enrollment target is 71 participants, below the 269-participant average among 38 other Presbyopia trials with a reported enrollment target (74% lower). The trial reports 8 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06401551, a NA study of Presbyopia and Aphakia, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 71 participants
- Enrollment target
- 8
- Study locations
Study Summary
The purpose of this study is to evaluate the safety and effectiveness of Clareon™ PanOptix™ Pro Trifocal Intraocular Lens (IOL) compared to Clareon™ PanOptix™ Trifocal IOL.
Primary Outcome
Visual Acuity (VA) was assessed for each eye individually using Early Treatment Diabetic Retinopathy Study (ETDRS) reading charts at a distance of 4 meters from the subject under photopic (well-lit) conditions with correction in place. BCDVA was measured in logarithm Minimum Angle of Resolution (logMAR). LogMAR values typically range from -0.3 (20/10 vision on the Snellen chart) to 1 (20/200 vision), with lower scores indicating better vision.
Conditions Studied
Interventions
- DEVICE CPO Pro IOL
- DEVICE CPO IOL
- PROCEDURE Cataract Surgery
Study Locations (8)
California
- Wolstan & Goldberg Eye Associates - Torrance
Michigan
- Grosinger, Spigelman & Grey Eye Surgeons, P.C. - Bloomfield Hills
Missouri
- Moyes Eye Center - Kansas City
Ohio
- Cincinnati Eye Institute - Cincinnati
South Carolina
- Carolina Eye Care Physicians - Charleston
Tennessee
- Vision for Life - Nashville
Texas
- Houston Eye Associates - Houston
Utah
- The Eye Institute of Utah - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 71 participants |
| Start Date | 2024-06-18 |
| Est. Completion | 2025-04-30 |
| Phase | NA |
What the finished NCT06401551 record still lists
NCT06401551 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 71 participants, a relatively small participant target, below the 269-participant average among 38 other Presbyopia trials with a reported enrollment target (74% lower).
The record links to 2 conditions, with Presbyopia appearing as the primary indexed condition, and to 3 interventions - of which CPO Pro IOL is the first listed.
NCT06401551 lists 8 locations in 8 states (California, Michigan, Missouri).
Frequently Asked Questions
What is clinical trial NCT06401551 about?
NCT06401551 is a clinical study titled "Clareon PanOptix Pro vs. Clareon PanOptix - Study B". The purpose of this study is to evaluate the safety and effectiveness of Clareon™ PanOptix™ Pro Trifocal Intraocular Lens (IOL) compared to Clareon™ PanOptix™ Trifocal IOL.
What is the current status of trial NCT06401551?
This trial is currently completed. It is a NA study. The enrollment target is 71 participants. The study started on 2024-06-18. Estimated completion is 2025-04-30.
What conditions does trial NCT06401551 study?
This clinical trial studies the following conditions: Presbyopia, Aphakia.
What interventions are being tested in trial NCT06401551?
The interventions under investigation include: CPO Pro IOL (DEVICE), CPO IOL (DEVICE), Cataract Surgery (PROCEDURE).
Who is sponsoring clinical trial NCT06401551?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06401551 being conducted?
This trial has 8 study locations across California, Michigan, Missouri, Ohio, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Presbyopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06401551's enrollment target sits among peer trials
71 22nd of 38 higher than 17 of 38 other Presbyopia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Presbyopia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Post Market Clinical Evaluation of Clareon PanOptix Pro and Clareon PanOptix Pro Toric IOLs
RECRUITING · NA
-
A Clinical Comparison of Proclear® 1 Day Multifocal and Clariti® 1 Day Multifocal 3 Add
RECRUITING · NA
-
Presbyopic Wear Experience With Multifocal Lenses Compared to Single Vision Lenses and Reading Glasses
RECRUITING · NA
-
Clinical Applications of Advanced Ophthalmic Imaging
RECRUITING · NA
-
Post Market Clinical Follow-up (PMCF) Study of Clareon Vivity & Clareon PanOptix
ACTIVE NOT RECRUITING · NA
-
Clinical Evaluation of a Small Aperture Extended Depth of Focus Intraocular Lens
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05452889 · 71 participants · Early Phase 1
PET Image in PAH Patients
- NCT05766943 · 71 participants · NA
Reduction of Myopotential Interference With Smart Pass in S-ICD Patients
- NCT06229678 · 71 participants · Early Phase 1
Ketones, SGLT2, HFrEF
- NCT06377566 · 71 participants · Phase 2
A Study of BV-AVD in People With Bulky Hodgkin Lymphoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI